Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1): Potential risk factor for the acute coronary syndromes

European Heart Journal

Volumn 22, Issue 14, 2001, Pages 1226-1234

  O'Malley, T ^a   Ludlam, C A ^b   Riemermsa, R A ^c   Fox, K A A ^d  

^a Portiuncula Hospital   (Ireland)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c Cardiovascular Research Unit   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acute coronary syndrome; Inflammation; Intercellular adhesion molecule; Risk factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE DISEASE; ADULT; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RISK FACTOR;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; P-SELECTIN; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0034890021     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2480     Document Type: Article

References (37)

1. Inflammation, atherosclerosis, and ischemic events - Exploring the hidden side of the moon
2. Cell adhesion molecules in cardiovascular disease: What can soluble levels tell us?
3. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina
4. Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome
5. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischemic heart disease
6. Reperfusion injury after myocardial infarction: The role of free radicals and the inflammatory response
7. Circulating adhesion molecules in disease
8. Management strategies for a better outcome in unstable coronary artery disease
9. Role of inflammation in the pathogenesis of unstable coronary artery diseases
10. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease
11. Production of C-reactive protein and risk of coronary events in stable and unstable angina
12. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
13. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction
14. Elevation of C-reactive protein in 'active' coronary artery disease
15. C-reactive protein elevation and early outcome in patients with unstable angina pectoris
16. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
17. Elevated levels of interleukin-6 in unstable angina
18. Unstable angina. A classification
19. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: A micromethod for the detection of platelet activation
20. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets
21. Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
22. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study
23. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
24. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities
25. Plasma concentration of soluble intercellular adhesion molecule l and risks of future myocardial infarction in apparently healthy men
26. The Berkson bias in action
27. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells
28. Expression of intercellular adhesion molecule-1 in rat heart with ischaemia/ reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules
29. Identification of a time window for therapy to reduce experimental canine myocardial injury: Suppression of neutrophil activation during 72 hours of reperfusion
30. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina
31. Increased levels of soluble adhesion molecules in atherosclerosis
32. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study
33. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors
34. Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris
35. Elevated platelet-derived microparticle levels during unstable angina
36. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: A pilot study